Mutual of America Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Mutual of America Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.64M	Buy	+27,733	New	+$1.85M	0.03%	699

Other funds holding ORKA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SAM

Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

Mutual of America Capital Management's ORKA Position: Q2 2026 in Review

Mutual of America Capital Management opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 27,733 shares worth $2.64M. The stake represents 0.03% of the portfolio and ranks #699 among its holdings.

101 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

Mutual of America Capital Management held 27,733 shares of Oruka Therapeutics worth $2.64M as of Q2 2026.
Oruka Therapeutics was a new Mutual of America Capital Management position in Q2 2026.
Oruka Therapeutics made up 0.03% of Mutual of America Capital Management's portfolio in Q2 2026, its #699 holding.
101 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.